Last reviewed · How we verify
NCT06216522
The Effectiveness of Topical Sesame Oil in Preventing Phlebitis at IV Cannula Sites in Adults
NA trial testing Topical Sesame Oil in Phlebitis in 263 participants. Completed in 21 October 2022.
21 October 2022
Quick facts
| Lead sponsor | National Heart Centre Singapore |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 263 |
| Start date | 12 April 2022 |
| Primary completion | 21 October 2022 |
| Estimated completion | 21 October 2022 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Topical Sesame Oil
- Liquid paraffin oil
Conditions studied
- Phlebitis — all drugs for Phlebitis →
- Thrombophlebitis — all drugs for Thrombophlebitis →
Sponsor
National Heart Centre Singapore — full company profile →
Who can join
Adults 21 to 80, any sex, with Phlebitis or Thrombophlebitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomised controlled trial is to determine the effectiveness of topical sesame oil in preventing phlebitis at peripheral intravenous (IV) cannula sites in adult patients within a cardiovascular and cardiothoracic department of a tertiary hospital. The main question it aims to answer is: Is topical sesame oil effective in preventing phlebitis at peripheral IV cannula sites in adult patients within a cardiovascular and cardiothoracic department of a tertiary hospital? Participants will be randomly allocated to the experimental or control group with the use of a randomisation software (MS excel). They will each have five drops/0.25mls of 100% sesame oil (experimental) or liquid paraffin oil (control) applied to the IV cannula site, at 12 hourly intervals for a total of 72 hours, from 3cm above the insertion point to 10cm along the vein, with a width of 2cm on either side. Researchers will compare the phlebitis incidence and severity of each group to see if topical sesame oil is more effective than liquid paraffin oil in preventing phlebitis at IV cannula sites in adult patients within a cardiovascular and cardiothoracic department of a tertiary hospital.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06216522
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Phlebitis
Currently open trials in the same condition.
- NCT06770374 — Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Ca · NA · recruiting
- NCT06375850 — Effects of Topical Sesame Oil in the Prevention of Peripheral Venous Catheter Phlebitis: Clinical Trial. · NA · recruiting
Other National Heart Centre Singapore trials
Trials by the same sponsor.
- NCT06645691 — Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body · Phase 2 · recruiting
- NCT05912218 — REducing Diabetic MacrovascUlar Complications DuE to Peripheral Arterial Disease- REDUCE-PAD · Phase 2 · active not recruiting
- NCT05946174 — Tackling Disruptions to Frailty Interventions: Developing Personalized Interventions Targeted for Older Persons With Car · NA · recruiting
- NCT05775484 — Exercise to Slow Cardiovascular Ageing Progression · recruiting
- NCT07376993 — Pulse Signal Acquisition in Patients With Heart Failure · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06216522 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Heart Centre Singapore
- Last refreshed: 21 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06216522.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing